Constellium is trading 4.1% up at $25.39 on October 5, 2026; available coverage does not establish a specific reason for the move. - No clear company-specific announcement explaining the gain surfaced in available coverage. - Indexes are modestly higher, but the broader market move does not clearly account for Constellium’s larger gain. - The latest identified analyst action was Wells Fargo’s September 18 price-target reduction, not a new catalyst for this session.